Prominent relief against OCULAR INFLAMMATION
Moxifloxacin 5mg+Loteprednol Etabonate 5mg
MOXIFLOXACIN
- High clinical success rate against common ocular pathogens
- Upto 94% micro-biological eradication rate in bacterial conjunctivitis
LOTEPREDNOL
- Reduces signs and symptoms of postoperative anterior chamber inflammation
- Acceptable safety profile
Steroid-responsive inflammatory conditions with superficial bacterial infection such as :
- Infective Conjunctivities
- Milk Anterior Uveitis
- Post-ocular surgery
- Acute Allergic Conjunctivities
- Corneal injury from chemical or themal burns